ROPIVACAINE B.BRAUN SOLUTION FOR INJECTION AND INFUSION 2MG/ML
Product details
Registration number: SIN17164P
Classification: Prescription Only
Active ingredients: Ropivacaine hydrochloride
Strength: 2mg/ml
Dosage form: INJECTION, SOLUTION
Route: EPIDURAL; PERINEURAL
Registrant: B. BRAUN SINGAPORE PTE LTD
ATC code: N01BB09
HSA approval date: 16 January 2025
Manufacturer(s): B. Braun Medical S.A.
Manufacturing country/countries: SPAIN
What are the HSA registration number and classification for ROPIVACAINE B.BRAUN SOLUTION FOR INJECTION AND INFUSION 2MG/ML?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN17164P
Classification: Prescription Only
What active ingredients and strength are recorded for ROPIVACAINE B.BRAUN SOLUTION FOR INJECTION AND INFUSION 2MG/ML?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Ropivacaine hydrochloride
Strength: 2mg/ml
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for ROPIVACAINE B.BRAUN SOLUTION FOR INJECTION AND INFUSION 2MG/ML?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, SOLUTION
Route: EPIDURAL; PERINEURAL
Who is the recorded registrant for ROPIVACAINE B.BRAUN SOLUTION FOR INJECTION AND INFUSION 2MG/ML?
According to the HSA dataset updated 7 August 2026:
Registrant: B. BRAUN SINGAPORE PTE LTD
Which manufacturers and countries are listed for ROPIVACAINE B.BRAUN SOLUTION FOR INJECTION AND INFUSION 2MG/ML?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): B. Braun Medical S.A.
Manufacturing country/countries: SPAIN
Where can I look up ROPIVACAINE B.BRAUN SOLUTION FOR INJECTION AND INFUSION 2MG/ML in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN17164P or the exact product name ROPIVACAINE B.BRAUN SOLUTION FOR INJECTION AND INFUSION 2MG/ML. The general register link does not preselect this product.
What are the source dates for this ROPIVACAINE B.BRAUN SOLUTION FOR INJECTION AND INFUSION 2MG/ML record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this ROPIVACAINE B.BRAUN SOLUTION FOR INJECTION AND INFUSION 2MG/ML record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN17164P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)